Saudi Arabia Blood Glucose Device Market Overview
The Saudi Arabia Blood Glucose Device Market is projected to grow from US$ 143.96 million in 2024 to US$ 259.8 million in 2033, registering a CAGR of 6.78% over the forecast period 2025–2033. The market growth is primarily driven by the rising prevalence of diabetes, increasing health awareness, and government initiatives promoting early diagnosis and self-monitoring of blood glucose levels. Technological innovations in continuous glucose monitoring (CGM) systems and user-friendly glucometers are also enhancing patient compliance and improving overall disease management.
Full Access Report:https://www.renub.com/saudi-arabia-blood-glucose-device-market-p.php
Market Outlook
A blood glucose meter is a medical device that measures glucose levels in the bloodstream, playing a crucial role for individuals with diabetes in managing their condition. Commonly used devices include glucometers, continuous glucose monitors (CGM), and flash glucose monitors, providing either real-time or interval glucose readings. Effective monitoring helps prevent complications such as hypoglycemia, hyperglycemia, and chronic organ damage.
In Saudi Arabia, the demand for blood glucose monitoring devices has surged due to the high and increasing prevalence of diabetes. Factors such as sedentary lifestyles, high-calorie diets, and rising obesity rates are contributing to this trend. Government initiatives, public health campaigns, and increased access through pharmacies and online platforms are further driving adoption across urban and rural communities.
Growth Drivers
Increased Type 2 Diabetes Prevalence
Type 2 diabetes is widespread among Saudi Arabia’s adult population. Contributing factors include inactive lifestyles, poor dietary habits, and rising obesity levels. With increasing awareness, more individuals are opting for self-monitoring devices for regular glucose checks and early intervention. According to the International Diabetes Federation (IDF), over 4.27 million people in Saudi Arabia had diabetes in 2023, with an additional 1.86 million undiagnosed. This number is projected to reach 5.6 million by 2030 and 7.5 million by 2045, fueling continuous demand for blood glucose devices.
Technological Advancements and User-Friendly Devices
Modern devices, including CGMs, Bluetooth-enabled glucometers, and non-invasive sensors, offer higher accuracy, real-time monitoring, and smartphone connectivity. Features such as smaller sizes, painless testing, and intuitive interfaces improve adoption among younger and older populations.
For instance, in August 2023, Nemaura Medical received SFDA approval for its non-invasive glucose sensor wearable, sugarBEAT, a Class IIb medical device providing continuous daylong glucose monitoring and tracking of daily glucose patterns.
Government Programs and Public Health Campaigns
Saudi Arabia’s Vision 2030 healthcare reforms emphasize disease prevention, early diagnosis, and chronic disease management. Government-supported screening programs, school and workplace awareness campaigns, and partnerships with healthcare providers are improving early detection rates. Subsidies, insurance coverage, and hospital-based monitoring equipment further increase accessibility.
For example, in 2024, the Saudi Ministry of Health partnered with Ithnain to coach over 10,000 diabetes patients, aligning with Vision 2030 objectives for better healthcare delivery and widespread awareness.
Market Challenges
High Cost of Advanced Devices
Despite benefits, CGMs and smart glucometers are expensive, and insurance coverage is often limited. High costs restrict access, especially for low- and middle-income populations, making widespread adoption a challenge.
Limited Awareness and Compliance in Rural Areas
Urban regions like Riyadh and Jeddah benefit from advanced healthcare facilities and awareness programs, whereas rural areas face limited access and understanding of glucose monitoring. This gap affects early diagnosis and adherence to regular monitoring, hindering nationwide adoption.
👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Sample Report:https://www.renub.com/request-sample-page.php?gturl=saudi-arabia-blood-glucose-device-market-p.php
Market Segments
By Product
· Test Strips: Essential for spot-checking glucose levels, widely used for Type 2 diabetes. Affordability and convenience drive popularity, though recurring costs can accumulate over time.
· Lancets: Used for finger-prick blood sampling, critical for conventional glucometers.
· Blood Glucose Meters: Include traditional glucometers, CGMs, and flash monitors offering real-time or intermittent readings.
By Application
· Type 1 Diabetes
· Type 2 Diabetes
· Gestational Diabetes
By End User
· Hospital Pharmacies: Key distribution points offering education, device training, and subsidized access.
· Retail Pharmacies: Chains such as Al Nahdi, White Pharmacy, and Al-Dawaa provide wide product availability, loyalty programs, and online sales options.
· Online Sales: Expanding accessibility in urban and rural regions.
· Diabetes Clinics & Centers: Specialized patient management and monitoring services.
By Region / City
· Dhahran: Affluent population, strong private healthcare penetration, high adoption of sophisticated devices, and educational programs.
· Riyadh: Capital city with the highest market density, advanced hospitals, specialty centers, and high adoption of smart devices.
· Jeddah: Growing prevalence of Type 2 diabetes, robust health infrastructure, strong adoption of wearable glucose monitors, and health awareness programs.
· Khobar, Dammam, Others: Contributing to the overall regional growth.
Competitive Landscape
Key players in the Saudi Arabia blood glucose device market are analyzed across overviews, key personnel, recent developments, SWOT analysis, and revenue insights:
· Abbott Laboratories
· Medtronic
· Dexcom Inc.
· B. Braun Melsungen AG
· DarioHealth Corp
· Sanofi
· Bionime Corporation
· Novo Nordisk
These players are introducing innovative CGMs, non-invasive sensors, and app-connected devices to enhance patient engagement, compliance, and glucose management.
Conclusion
The Saudi Arabia Blood Glucose Device Market is expected to witness steady growth from 2025 to 2033, fueled by the rising prevalence of diabetes, technological advancements, and government-led initiatives promoting early diagnosis and self-monitoring. While challenges such as device costs and limited rural awareness exist, increasing accessibility through hospital and retail pharmacies, online platforms, and public health campaigns is expanding market penetration. Major cities like Riyadh, Dhahran, and Jeddah are leading adoption, while rural outreach programs are expected to enhance nationwide use. With continuous innovation and supportive healthcare policies, the market holds significant potential for both domestic and international players.
👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report:https://www.renub.com/request-customization-page.php?gturl=saudi-arabia-blood-glucose-device-market-p.php
Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.
Sign in to leave a comment.